Phathom Pharmaceuticals (PHAT) Other Gross PP&E Adjustments: 2022-2025
Historic Other Gross PP&E Adjustments for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to -$3.0 million.
- Phathom Pharmaceuticals' Other Gross PP&E Adjustments fell 247.23% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.5 million, marking a year-over-year decrease of 142.32%. This contributed to the annual value of $2.5 million for FY2024, which is 164.38% up from last year.
- Per Phathom Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$3.0 million for Q3 2025, which was down 198.41% from -$1.0 million recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $2.5 million during Q4 2024, and its lowest value of -$4.8 million during Q2 2022.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$688,000 (2023), whereas its average is $36,818.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 396.08% in 2024, then tumbled by 247.23% in 2025.
- Quarterly analysis of 4 years shows Phathom Pharmaceuticals' Other Gross PP&E Adjustments stood at -$2.6 million in 2022, then skyrocketed by 136.26% to $946,000 in 2023, then spiked by 164.38% to $2.5 million in 2024, then crashed by 247.23% to -$3.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$3.0 million for Q3 2025, versus -$1.0 million for Q2 2025 and -$1.0 million for Q1 2025.